CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-06 | Monohon Ted Chief Accounting Officer & VP | Sale | −1,871 | $0.98 | $2K | 27,440 |
| 2023-02-01 | Monohon Ted Chief Accounting Officer & VP | Grant or award · Employee Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2022-12-05 | Monohon Ted Chief Accounting Officer & VP | Shares withheld for taxes | −1,640 | $0.72 | $1K | 29,311 |
| 2022-09-06 | Monohon Ted Chief Accounting Officer & VP | Shares withheld for taxes | −1,520 | $1.64 | $2K | 30,951 |
| 2022-06-29 | Monohon Ted Chief Accounting Officer & VP | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2022-06-06 | Monohon Ted Chief Accounting Officer & VP | Shares withheld for taxes | −1,529 | $3.12 | $5K | 32,471 |
| 2022-03-03 | Monohon Ted Chief Accounting Officer & VP | Grant or award | +34,000 | 34,000 | ||
| 2021-12-14 | Monohon Ted Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-02-09 | Monohon Ted Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 |
Page 1 of 1 · 9 trades